Andhra Pradesh places order for 40 mn doses each of Covaxin, Covishield

The Andhra Pradesh government on Saturday placed an order for purchase of 40 mn doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1

Coronavirus vaccine, Covid-19 vaccine, Covid vaccine
Photo: Shutterstock
Press Trust of India Amaravati
1 min read Last Updated : Apr 24 2021 | 6:09 PM IST

: The Andhra Pradesh government on

Saturday placed an order for purchase of 4.08 crore doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1.

Government Principal Secretary (Covid Management and Vaccination) Muddada Ravichandra wrote letters to Bharat Biotech MD Krishna Yella and Serum Institute of India Limited CEO Adar Poonawalla in this regard.

Chief Minister Y S Jagan Mohan Reddy had announced on Friday that all 2.04 crore people in the 18-45 age group would be given the coronavirus vaccine free-of-cost from May 1.

"Extensive arrangements are made at the State Vaccine Stores (Gannavaram), regional and district vaccine stores with state-of-the-art equipment for maintenance of vaccines and proper linkage of supply and monitoring.

A mechanism to vaccinate over six lakh people per day is already in place in our state,"Ravichandra said in the letter.

The Principal Secretary said the government was committed to vaccinate all people on a mission mode.

"Hence, the vaccine doses may be supplied, as early as possible, directly to the state government and payment shall be made as per the commercials, as per rules," he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineBharat BiotechSerum Institute of IndiaAndhra Pradesh

First Published: Apr 24 2021 | 6:05 PM IST

Next Story